US Oncology Director of Finance Salaries in Boulder | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Director of Finance Salaries in Boulder

The average US Oncology Director of Finance in Boulder earns an estimated $118,343 annually. US Oncology's Director of Finance compensation is $43,673 less than the US average for a Director of Finance.

In Boulder, The Finance Department at US Oncology earns $6,646 more on average than the Operations Department.

Last updated 7 months ago.

$30k
$74k
$117k
$159k
$350k
$600k
$118,343
Average Compensation
$118,343
avg. base

Director of Finance Salaries at US Oncology

In Boulder, Directors of Finance earn $20,519 more than Accounting Managers.

Accounting Manager
$98k*
Senior Accountant
$92k*
Business Analyst
$80k*
Financial Analyst
$74k*
Accountant
$71k*
* estimated salary

Compensation at US Oncology by Department

In Boulder, The Finance Department averages $6,646 more than the Operations Department, and $14,071 less than the Sales Department

Sales
$91,161 Avg. total comp.
+$14k
Finance
$77,090 Avg. total comp.
Operations
$70,444 Avg. total comp.
-$7k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to US Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to US Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at US Oncology Rate Their Compensation

The majority of Directors of Finance at US Oncology believe they're compensated fairly. 50% of Directors of Finance at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company